Artelo Biosciences Inc

NASDAQ:ARTL  
0.56
-0.05 (-8.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Artelo Biosciences Inc Stock, NASDAQ:ARTL

505 Lomas Santa Fe, Suite 160, Solana Beach, California 92075
United States of America
Phone: +1.858.925.7049
Number of Employees: 5

Description

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded by James Manley on May 2, 2011 and is headquartered in Solana Beach, CA.